“Few stocks in the small- and mid-cap segment have multiplied, and strong momentum is taking them beyond the fair value of businesses,” said Kotak in a letter to investors. “We believe our funds are positioned defensively, emphasising the quality of businesses. However, given the market background, we see it prudent to limit the inflows in our Small Cap Fund at this juncture.”
Right time to take profit off the table in pharma; defence a structural buy: Rajiv Batra
Rajiv Batra addresses global investors’ concerns about India’s growth and policy, emphasizing the need for double-digit earnings and nominal GDP growth to reignite foreign investor
August 22, 2025